Mesoblast (MEOBF) director Jane Bell reports options and 622,492 shares

Rhea-AI Filing Summary

Mesoblast Ltd director Jane Catherine Bell has filed an initial Form 3 reporting her equity interests in the company. The filing lists multiple options to buy Ordinary Shares, including options over 108,910 shares at an exercise price of 0.3600 per share expiring on 2030-10-11, and options over 64,103 shares at an exercise price of 0.9700 per share expiring on 2031-08-26. It also reports indirect ownership of 622,492 Ordinary Shares held by Ms. Bell and Geoffrey Arthur Bell as trustees for Ms. Bell's self-managed superannuation fund.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BELL JANE CATHERINE

(Last) (First) (Middle)

LEVEL 38

55 COLLINS STREET

(Street)

MELBOURNE, VICTORIA 3000

(City) (State) (Zip)

AUSTRALIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
MESOBLAST LTD [ MESO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	622,492	I	By Ms. Bell and Mr. Geoffrey Arthur Bell as trustees for Ms. Bell's self-managed superannuation fund

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	08/24/2023	08/23/2029	Ordinary Shares	66,667	$0.83	D
Option (right to buy)	04/12/2024	10/11/2030	Ordinary Shares	108,910	$0.36	D
Option (right to buy)	07/12/2024	10/11/2030	Ordinary Shares	108,910	$0.36	D
Option (right to buy)	08/24/2024	08/23/2029	Ordinary Shares	66,667	$0.83	D
Option (right to buy)	10/12/2024	10/11/2030	Ordinary Shares	108,909	$0.36	D
Option (right to buy)	02/27/2025	08/26/2031	Ordinary Shares	64,103	$0.97	D
Option (right to buy)	05/27/2025	08/26/2031	Ordinary Shares	64,103	$0.97	D
Option (right to buy)	08/24/2025	08/23/2029	Ordinary Shares	66,666	$0.83	D
Option (right to buy)	08/27/2025	08/26/2031	Ordinary Shares	64,102	$0.97	D

Explanation of Responses:

Remarks:

1. All exercise prices are in Australian dollars.

	/s/ Jane Catherine Bell	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Mesoblast (MEOBF) director Jane Catherine Bell report on her Form 3?

Jane Catherine Bell reports her existing equity interests in Mesoblast Ltd, including several option positions over Ordinary Shares and an indirect holding of 622,492 Ordinary Shares through a self-managed superannuation fund, reflecting her baseline ownership as she becomes a reporting insider.

What stock options held by Jane Catherine Bell in Mesoblast (MEOBF) are disclosed?

The Form 3 lists options to buy Mesoblast Ordinary Shares, including tranches over 108,910 shares at an exercise price of 0.3600 per share and 64,103 shares at 0.9700 per share, with expirations extending to 2030-10-11 and 2031-08-26.

How many Mesoblast (MEOBF) Ordinary Shares does Jane Catherine Bell indirectly hold?

The filing reports indirect ownership of 622,492 Mesoblast Ordinary Shares. These shares are held by Ms. Bell and Geoffrey Arthur Bell as trustees for Ms. Bell's self-managed superannuation fund, indicating trustee-held beneficial ownership rather than direct personal registration in her own name.

Are there any buy or sell transactions in Jane Catherine Bell’s Mesoblast (MEOBF) Form 3?

No buy or sell transactions are reported. The Form 3 records holdings only, with transaction codes and directions shown as unknown and transaction_type marked as holding, indicating this is an initial statement of beneficial ownership rather than a record of recent trades.

What is the significance of the expiration dates on Jane Catherine Bell’s Mesoblast (MEOBF) options?

The expiration dates, running through 2029-08-23, 2030-10-11 and 2031-08-26, show how long Ms. Bell retains the right to buy Mesoblast Ordinary Shares at specified exercise prices, outlining a multi-year window for potential future share acquisitions.

Does Jane Catherine Bell hold Mesoblast (MEOBF) shares directly as well as indirectly?

The data show direct holdings in the form of options over Mesoblast Ordinary Shares and indirect ownership of 622,492 Ordinary Shares via a self-managed superannuation fund. Direct common-share ownership beyond the options is not listed in the provided excerpt.